Protective Effects of High-Fat Diet against Murine Colitis in Association with Leptin Signaling and Gut Microbiome

Abstract

Inflammatory bowel disease (IBD) is characterized by chronic intestinal-tract inflammation with dysregulated immune responses, which are partly attributable to dysbiosis. Given that diet plays a critical role in IBD pathogenesis and progression, we elucidated the effects of a high-fat diet (HFD) feeding on IBD development in relation to immune dysfunction and the gut microbiota. Five-week-old male C57BL/6J mice were fed either a normal diet (ND) or HFD for 14 weeks. The animals were further divided into ND, ND+ dextran sulfate sodium (DSS), HFD, and HFD+DSS treatment groups. The HFD+DSS mice exhibited lower body weight loss, lower disease activity in-dex, longer colon length, and increased tight-junction protein expression and goblet-cell propor-tions compared with the ND+DSS mice. The T helper (h)1 and Th17 cell populations and pro-in-flammatory cytokines involved in colitis pathogenesis were significantly more reduced in the HFD+DSS mice than in the ND+DSS mice. The HFD+DSS mice showed significantly increased serum leptin concentrations, colonic leptin receptor expression, enhanced anti-apoptotic AKT expres-sion, and reduced pro-apoptotic MAPK and Bax expression compared with the ND+DSS mice, sug-gesting the involvement of the leptin-mediated pathway in intestinal epithelial cell apoptosis. The alterations in the gut-microbiota composition in the HFD+DSS group were the opposite of those in the ND+DSS group and rather similar to those of the ND group, indicating that the protective effects of HFD feeding against DSS-induced colitis are associated with changes in gut-microbiota compo-sition. Overall, HFD feeding ameliorates DSS-induced colitis and colonic mucosal damage by rein-forcing colonic barrier function and regulating immune responses in association with changes in gut-microbiota composition. ? 2022 by the authors. Licensee MDPI, Basel, Switzerland.